Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
8 December 2016
Header
Header image
Highlight of the week

Highlight of the week

Webinars on IMI 2 Call 10
06 December 2016

From 7 December, IMI will hold webinars on each topic of the IMI 2 10th Call for proposals, as well as on IMI2 rules and procedures.

All webinars on the Call topics will feature a presentation by the EFPIA topic coordinator and time for questions and answers. The webinars will be an excellent opportunity to learn more about the topics, ask questions to topic coordinators and the IMI Programme Office representatives, and get in touch with potential project partners. 

The webinar on IMI’s new rules and procedures will also include presentations of IMI's intellectual property policy and tips on the preparation of proposal submissions.

Check the webinar schedule

Read more

Highlight of the week

Highlights from the Health Collaboration Summit 2016
08 December 2016

In collaboration with UCB, we have created a short video of the Health Collaboration Summit, held on 9-10 November, in Brussels. Listen to speakers and patient representatives sharing their takeaways from the event.

Watch the video

Read more

News

News

Europe must remain the world leader in excellent and responsible biomedical research
06 December 2016

In line with Directive 2010/63 on the protection of laboratory animals, the pharmaceutical industry, which, together with other life science players, develops continuously new scientific [...] Read more

From our blog

From our blog

Health Collaboration Awards 2016: To live with epilepsy
08 December 2016 by

The EFPIA Patient Think Tank established the Health Collaboration Awards in 2015, to share best practice in collaborative projects that address healthcare needs. Entrants include collaborations between patient organisations, industry, local authorities, healthcare systems and other key actors in delivering healthcare.

The winners of the 2016 edition of the Awards were announced at the Health Collaboration Summit, which took place on 9-10 November, in Brussels.

This week, we focus on the winner of The Prevention and Awareness Award: To live with epilepsy.

Read more

Events calendar

Events Calendar

Optimising the Development of ATMPs to Meet Patient Needs - The fifth annual regulatory conference organised by the European Biopharmaceutical Enterprises (EBE) in collaboration with the European Medicines Agency (EMA)
On 16/12/2016 (London, UK)

Europe is a world-leader in the development of cutting edge Advanced Therapies Medicinal Products (ATMPs) including gene therapies. This conference, organised in collaboration with the EMA, will feature a gathering of international thought-leaders who will highlight initiatives to improve the access to ATMPs for patients, as well as outline the needs for their development and commercialisation within the EU.

For more information on the programme and to register, click here.

Read more

Events Calendar

The Evolving Role of Publication Professionals in a Multi-Stakeholder Environment - European Meeting of the International Society for Medical Publication Professionals (ISMPP)
From 17/01/2017 to 18/01/2017 (London, UK)

The 2017 European Meeting of the International Society for Medical Publication Professionals (ISMPP) will be held 17-18 January, in London, UK, and it will focus on “The Evolving Role of Publication Professionals in a Multi-Stakeholder Environment”. Two full days of educational programming will provide networking opportunities, interactive roundtables, plenary sessions, member research, and exhibitors displaying cutting edge products and services.

Read more

Events Calendar

Patients as Partners Europe
From 06/02/2017 to 07/02/2017 (London, UK)

Patients as Partners Europe is the only conference putting the patient voice on the same level as industry and government in finding solutions to engage and empower patients in the clinical development and trial process. Join clinical trial leaders from Pharma, Patient Advocacy and Goverment. The programme is co-located with DPharm Europe. 

Read more

Documents

From our blog

Posters: 3Rs: Replace, Reduce, Refine - Minimising Impact & Reducing Numbers
05 December 2016 (Publications)

The pharmaceutical sector continue to be involved in a number of initiatives, which affirm the key principles of the 3Rs (Reducing the number of animals used, Refining experiments [...] Read more

What we are reading

What we are reading

Ensuring responsible research & animal welfare across Europe
08 December 2016 (EurActiv)

Guest blog posat by: Sam Alvis, Policy Officer, Wellcome Trust; Tom Van de Putte, Policy Adviser, FWO, Phillip Hahn, Helmholtz Association.

Over 66% of European citizens support the use of animals in research, which at this time is an essential tool to better our understanding of human, animal and environmental health and biology. It’s important to society that the potential public benefits outweigh the costs to the animals, and that no alternative methods are available. It’s also crucial that high ethical and welfare standards are met. As funding agencies of medical, biological and environmental research, we play a central role in ensuring that the world leading scientific work we fund is consistently meeting these standards.

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail